Recent advances in immunotherapy and combination therapies are revolutionizing the treatment landscape for both metastatic ...

Robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy for bladder cancer offers better perioperative outcomes.

According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for ...

UC Davis Comprehensive Cancer Center is the first in the region to offer a new groundbreaking clinical trial for bladder ...

Town of Dunkirk resident Sue Hazelton is never shy to bring something before the Town Board during public comments. At the ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it has surpassed a ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated ...

In an interview, Antoni Vilaseca Cabo, MD, discussed the clinical activity of TAR-210 in patients with non-muscle invasive ...

Biodexa-ClinicalPrograms Biodexa?s clinical programs from left to right: MTX110 for rGBM brain cancer, Tolimidone for Type 1 ...

The following is a summary of “Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder ...

Details on the late-breaking abstract and posters are as follows: Topline Results from BOND-003: A Phase-3 Study of Intravesical Cretostimogene Grenadenorepvec for the Treatment of High-Risk ...

The #ESMOAmbassadors hashtag was used in 1,907 posts on X across the five-day congress. The 28 ESMO Ambassadors themselves ...